Ashok Choudhury: Portal Vein Thrombosis and Outcomes in Cirrhosis
Ashok Choudhury, Gastroenterologist, Liver Transplant Physician, Professor at Institute of Liver and Biliary Sciences, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Liver Transplantation, adding:
“New publication | Portal Vein Thrombosis in Cirrhosis
Pleased to share this important global study examining the impact of portal vein thrombosis (PVT) among hospitalized patients with cirrhosis.
The multinational CLEARED cohort included 7,721 patients from 117 centers across 37 countries.
Some important findings:
- PVT was present in 10% of hospitalized patients with cirrhosis.
- 30-day mortality was 22.1% in patients with PVT compared with 18.0% without PVT.
- PVT was also associated with higher rates of acute kidney injury, severe hepatic encephalopathy, 30-day readmission and liver transplantation.
- After adjustment, PVT remained independently associated with increased short-term mortality. JOVE Visualize
These findings highlight the importance of identifying PVT early and recognizing these patients as a higher-risk group who may require closer inpatient management and post-discharge follow-up.”
Title: Portal vein thrombosis increases short-term mortality among hospitalized patients with cirrhosis in a global cohort.
Authors: Ashok Choudhury, Scott Silvey, Florence Wong, Patrick S Kamath, Jacob George, Ramazan Idilman, Mark Topazian, Aldo Torre, Mário Reis Álvares-da-Silva, Qing Xie, Peter Hayes, Wai Kay Seto, Shiv K Sarin, Jacqueline Cordova-Gallardo, Suresh Vasan Venkatachalapathy, Xiangmei Wang, Patricia Zitelli, Hak-Keith Leung, Hibat Allah Belimi, Bin Xu, Francisco Félix-Tellez, Robert Livingstone, Mingqin Lu, Feng Peng, Busra Haktaniyan, Liou Wei Lun, Shalimar, Ashish Goel, K Rajender Reddy, Katina Zheng, Surender Kumar, Mohammad Rela, Ajay Jhaveri, Richard Goodheart, Dinç Dinçer, Kessarin Thanapirom, Henok Fisseha, Yue Wang, Sarai Gonzalez Hueso, Lilian Torres Made, Paula Guedes, Neil Rajoriya, Tao Li, Cameron Gofton, Harendran Elangovan, Gerry MacQuillan, Luis Garrido Trevino, Wei Wang, Stephen Riordan, Dibyalochan Praharaj, Anand V Kulkarni, Nabiha Faisal, Hasan Basri Yapici, Hugo Vargas, Helena Katchman, José Luis Pérez Hérnandez, Feng Guo, Marie Jeanne Lohoues, Ajay Duseja, Kaleb A Berhane, Ahmed Hakem, Huan Deng, Chenghai Liu, Scott W Biggins, Yashwi Haresh Kumar Patwa, Amey Sonavane, Michael Schultheiß, Punita Tandon, Shiva Kumar, Paul Thuluvath, Hong Tang, Xinrui Wang, Robert Gibson, Adrián Gadano, Ewan Marwan, Amany Zekry, Zeki Karasu, Alaa Mostafa, Anil Arora, Ningping Zhang, Cailian Cai, Arun Valsan, Ewan Forrest, Qinglang Xu, Xin Zheng, Hai Li, Yongchao Xian, Andrew Keaveny, Zhiliang Gao, Elizabeth Verna, Yu Jun Wong, Babatunde Duduyemi, Brian J Bush, Jasmohan S Bajaj

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines